Arthritis, Rheumatism and Aging Medical Information System Post-Marketing Surveillance Program.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 11361209.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The Arthritis, Rheumatism, and Aging Post-Marketing Surveillance Program (ARAMIS-PMS) is a collection of multicenter, prospective, noninterventional, observational longitudinal studies of patients with rheumatic diseases. The ARAMIS-PMS program aims to study patients in normal clinical setting to evaluate the real-life effectiveness, toxicity, and cost effectiveness of various medications used to treat rheumatic diseases.
Medical subject headings
- Adverse Drug Reaction Reporting Systems
- Aging
- Antirheumatic Agents
- Arthritis
- Product Surveillance, Postmarketing